Sight Sciences, Inc.

NASDAQ:SGHT

Medical - Devices

Healthcare
$10.77 +2.89%

+$0.15 today

Market cap
$598.59M
Beta
2.40
P/E (TTM)
-7.5
EPS (TTM)
-$0.69
52W Low $3.11High $9.24

Volume 0.34M

Average 0.25M

SGHT Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

Sight Sciences, Inc.NASDAQ: SGHT

Weighted Avg Shares · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares grows in line with its trailing trend

Q1 FY2026 weighted avg shares of 53.94M shares rose 5.2% year over year, ahead of the +4.4% change in trailing-twelve-month weighted avg shares. Sequentially, it rose 1.6% from the prior quarter. Over 3 fiscal years it compounded at +2.9% a year.

Context

  • Weighted avg shares increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +5.2% holds above the trailing-twelve-month pace of +4.4%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
53.94M+1.6% QoQ
Last fiscal yearDec 2025
52.15M+4.0% YoY
LTMMar 2026
52.81M+4.4% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+5.2%——
1 year+4.0%——
3-year CAGR+2.9%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2025
52.15M USD
Year-over-year change
+4.0%
4-year CAGR
+2.4%

Weighted Avg Shares vs competitors

How SGHT compares with its peers on the latest reported figures

  • SGHT's LTM Mar 2026 weighted avg shares of 52.81M shares is the 5th highest of the 7 companies compared; the peer median is 129.36M shares.
  • Its year-over-year change of +4.4% is the 2nd highest of 6, against a peer median of +3.1%.
  • Over three fiscal years its annual growth of +2.9% compares with a peer median of +6.4%.
SGHT Competitors Peer median
Weighted Avg Shares for SGHT and competitors
Company Period LTM YoY 3-year CAGR
ALCAlcon Inc.LTM Sep 2026486.05M -1.7%+0.2%
BHCBausch Health Companies Inc.LTM Jun 2026372.41M +0.6%+0.8%
OCULOcular Therapeutix, Inc.LTM Mar 2026200.88M +19.9%+34.5%
GKOSGlaukos CorporationLTM Jun 202657.84M +3.1%+6.4%
SGHTSight Sciences, Inc.LTM Mar 202652.81M +4.4%+2.9%
HROWHarrow Health, Inc.LTM Mar 202636.98M +3.5%+10.2%
SGPSpyGlass Pharma, Inc. Common StockFY202533.43M ——
Peer median (excluding SGHT) 129.36M+3.1%+6.4%

Competitors are the stored peer set for SGHT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue48.96M71.33M81.06M79.87M77.36M
Cost of Revenue8.61M12.36M11.88M11.58M10.7M
Gross Profit40.35M58.97M69.18M68.29M66.67M
Gross Margin82.4%82.7%85.3%85.5%86.2%
Research & Development15.63M22.86M17.56M17.99M14.61M
Selling, General & Admin76.19M120.07M108.89M100.83M89.16M
Operating Expenses91.82M142.92M126.45M118.82M103.77M
Depreciation & Amortization1.2M1.25M614K712K487K
EBITDA(57.21M)(80.48M)(49.42M)(45.9M)(32.79M)
EBITDA Margin-116.8%-112.8%-61.0%-57.5%-42.4%
Operating Income(51.48M)(83.95M)(57.27M)(50.53M)(37.1M)
Operating Margin-105.2%-117.7%-70.7%-63.3%-48.0%
Interest Income00003.97M
Interest Expense4.37M4.47M5.41M4.66M5.14M
Other Income / Expenses(11.29M)(2.24M)1.84M(739K)(1.32M)
Income Before Tax(62.77M)(86.2M)(55.44M)(51.27M)(38.42M)
Pre-Tax Margin-128.2%-120.8%-68.4%-64.2%-49.7%
Income Tax Expense188K47K110K236K10K
Net Income(62.96M)(86.24M)(55.55M)(51.51M)(38.43M)
Net Margin-128.6%-120.9%-68.5%-64.5%-49.7%
EPS (Basic)(1.33)(1.80)(1.14)(1.03)(0.74)
EPS (Diluted)(1.33)(1.80)(1.14)(1.03)(0.74)
Weighted Avg Shares47.5M47.85M48.63M50.13M52.15M
Weighted Avg Shares (Diluted)47.5M47.85M48.63M50.13M52.15M

Sight Sciences, Inc.

NASDAQ:SGHT

Intrinsic Alpha fair value

Locked

Current Price

$10.77

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.